CoChat

CTLA-4 and PD-1 Control of T-Cell Motility and Migration: Implications for Tumor Immunotherapy

Open access
Brunner-Weinzierl, Monika C., Rudd, Christopher E. · 2018 · Frontiers in Immunology
Cited by 153

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

CTLA-4 is a co-receptor on T-cells that controls peripheral tolerance and the development of autoimmunity. Immune check-point blockade (ICB) uses monoclonal antibodies (MAbs) to block the binding of inhibitory receptors (IRs) to their natural ligands. A humanised antibody to CTLA- 4 [Ipilimumab] was first approved clinically followed by antibody blockade of PD-1 [Nivolumab and Pembrolizumab] and its ligand PD-L1 [Atezolizumab](Baumeister et al., 2016; Okazaki et al., 2013; Page et al., 2014; Sharma et al., 2011) The function and mechanisms of action of CTLA-4 involve cell intrinsic and cell extrinsic pathways. Effective anti-tumour immunity requires the activation of tumour-specific effector T cells, the blockade of regulatory cells and the migration of T-cells into the tumour. In this review, we review data implicating CTLA-4 and PD-1 in the motility of T-cells with a specific reference to the potential exploitation of theses pathways for more effective tumour infiltration and eradication.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2018.02737

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 153

Metadata

Authors
Brunner-Weinzierl, M. C., & Rudd, C. E.
Venue
Frontiers in Immunology
Published
2018-11-27
Volume
9
Pages
2737-2737
ISSN
1664-3224 (ISSN-L)
OpenAlex
W2902690248
Cited by
153
References
20
FWCI
5.48
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CTLA-4 and PD-1 Control of T-Cell Motility and Migration: Implications for Tumor Immunotherapy. https://app.cochat.ai/papers/10.3389/fimmu.2018.02737
The paper
Brunner-Weinzierl, M. C., & Rudd, C. E. (2018). CTLA-4 and PD-1 Control of T-Cell Motility and Migration: Implications for Tumor Immunotherapy. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2018.02737

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.